Back to Search
CHRISTOPHER SCUDERI, D.O.
D.O.
Family Medicine Physician
NPI: 1760454037IndividualAccepts Medicare
Specialties, Licenses & Credentials
Family Medicine PhysicianPrimary
Family Medicine
Code: 207Q00000X
OS9323(FL)
CMS Specialties
PrimaryFAMILY PRACTICE
Education
LAKE ERIE COLLEGE OF OSTEOPATHIC MEDICINE, ERIE
Class of 2002
Research & Publications (20)
Differential cannabinoid receptor expression during reactive gliosis: a possible implication for a nonpsychotropic neuroprotection.
PMID 19347234·ScientificWorldJournal·2009
6-review
Congenital muscular dystrophies with defective glycosylation of dystroglycan: a population study.
PMID 19299310·Neurology·2009
4-observational
Posterior fossa abnormalities in hereditary spastic paraparesis with spastin mutations.
PMID 19289482·J Neurol Neurosurg Psychiatry·2009
8-other
Cannabidiol: a promising drug for neurodegenerative disorders?
PMID 19228180·CNS Neurosci Ther·2009
6-review
Cannabidiol in medicine: a review of its therapeutic potential in CNS disorders.
PMID 18844286·Phytother Res·2009
6-review
POMT1 and POMT2 mutations in CMD patients: a multicentric Italian study.
PMID 18513969·Neuromuscul Disord·2008
4-observational
S100B induces tau protein hyperphosphorylation via Dickopff-1 up-regulation and disrupts the Wnt pathway in human neural stem cells.
PMID 18494933·J Cell Mol Med·2008
8-other
Long-lasting complete remission with tyrosine kinase inhibitor in bronchioloalveolar carcinoma with a so far unknown EGFR mutation.
PMID 18379371·J Thorac Oncol·2008
5-case
Genomic and functional profiling of human Down syndrome neural progenitors implicates S100B and aquaporin 4 in cell injury.
PMID 17984171·Hum Mol Genet·2008
8-other
A phase II study of induction chemotherapy followed by concurrent chemoradiotherapy in elderly patients with locally advanced non-small-cell lung cancer.
PMID 17762402·Anticancer Drugs·2007
3-trial
Cannabinoid CB1 receptor stimulation affords neuroprotection in MPTP-induced neurotoxicity by attenuating S100B up-regulation in vitro.
PMID 17639288·J Mol Med (Berl)·2007
7-preclinical
Cannabidiol in vivo blunts beta-amyloid induced neuroinflammation by suppressing IL-1beta and iNOS expression.
PMID 17592514·Br J Pharmacol·2007
7-preclinical
Opposing control of cannabinoid receptor stimulation on amyloid-beta-induced reactive gliosis: in vitro and in vivo evidence.
PMID 17545311·J Pharmacol Exp Ther·2007
7-preclinical
Severe encephalomyopathy in a patient with homoplasmic A5814G point mutation in mitochondrial tRNACys gene.
PMID 17241783·Neuromuscul Disord·2007
5-case
CB1 receptor selective activation inhibits beta-amyloid-induced iNOS protein expression in C6 cells and subsequently blunts tau protein hyperphosphorylation in co-cultured neurons.
PMID 16837132·Neurosci Lett·2006
7-preclinical
Identification of novel mutations in patients with Coffin-Lowry syndrome by a denaturing HPLC-based assay.
PMID 16306095·Clin Chem·2005
8-other
LAMA2 gene analysis in congenital muscular dystrophy: new mutations, prenatal diagnosis, and founder effect.
PMID 16216942·Arch Neurol·2005
8-other
Familial breast cancer: characteristics and outcome of BRCA 1-2 positive and negative cases.
PMID 15996267·BMC Cancer·2005
8-other
Skewed X-inactivation in a family with mental retardation and PQBP1 gene mutation.
PMID 15811016·Clin Genet·2005
5-case
Two novel mutations in the spastin gene (SPG4) found by DHPLC mutation analysis.
PMID 15482961·Neuromuscul Disord·2004
4-observational
Data courtesy of the U.S. National Library of Medicine (NLM). Ltrl is not affiliated with or endorsed by NLM.
Contact & Hours
- Address
- 280 DUNDAS DR
JACKSONVILLE, FL 32218 - Phone
- (904) 902-1201
Quick Facts
- NPI
- 1760454037
- Entity Type
- Individual
- Gender
- Male
- Medicare
- Accepted
- Specialties
- 1
- Locations
- 1
- Years in Practice
- 24
- Publications
- 20
Are you this provider?
Claim Your Profile